FDA Approves New Seasonal Flu Vaccine Made Using Novel Technology

The U.S. Food and Drug Administration today announced that it has approved Flublok, the first trivalent influenza vaccine made using an insect virus (baculovirus) expression system and recombinant DNA technology.
Jan. 17, 2013
Sign up for Pharma Manufacturing Newsletters
Get the latest news and updates